These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 15298610
1. Helicobacter pylori-positive patients with pruritic skin diseases are at increased risk for gastric cancer. Shiotani A, Sakurane M, Furukawa F. Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():80-4. PubMed ID: 15298610 [Abstract] [Full Text] [Related]
2. Helicobacter pylori antibodies and gastric cancer: a gender-related difference. Janulaityte-Günther D, Kupcinskas L, Pavilonis A, Valuckas K, Percival Andersen L, Wadström T. FEMS Immunol Med Microbiol; 2005 May 01; 44(2):191-5. PubMed ID: 15866215 [Abstract] [Full Text] [Related]
3. Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer. Tanaka A, Kamada T, Yokota K, Shiotani A, Hata J, Oguma K, Haruma K. Pathol Res Pract; 2009 May 01; 205(10):690-4. PubMed ID: 19450936 [Abstract] [Full Text] [Related]
4. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A. Immunol Invest; 2007 May 01; 36(4):371-86. PubMed ID: 17691020 [Abstract] [Full Text] [Related]
5. Helicobacter pylori infection in gastric carcinoma. Kato T, Saito Y, Niwa M, Inoue H, Motoyama N, Ogoshi K, Nashimoto A, Sasaki J, Sato T, Asaka M. Eur J Gastroenterol Hepatol; 1994 Dec 01; 6 Suppl 1():S93-6. PubMed ID: 7735944 [Abstract] [Full Text] [Related]
6. [Helicobacter pylori infection in gastric cancer patients]. Ławniczak M, Starzyńska T. Pol Merkur Lekarski; 2002 Aug 01; 13(74):103-6. PubMed ID: 12420337 [Abstract] [Full Text] [Related]
7. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM. Int J Med Microbiol; 2006 Aug 01; 296(4-5):223-8. PubMed ID: 16600680 [Abstract] [Full Text] [Related]
8. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence. Vorobjova T, Ren Z, Dunkley M, Clancy R, Maaroos HI, Labotkin R, Kull K, Uibo R. APMIS; 2006 May 01; 114(5):372-80. PubMed ID: 16725014 [Abstract] [Full Text] [Related]
9. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains? Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O. Helicobacter; 2004 Jun 01; 9(3):271-7. PubMed ID: 15165264 [Abstract] [Full Text] [Related]
10. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, Kang HM, Lee HS, Jung HC, Song IS. J Clin Gastroenterol; 2008 Jun 01; 42(5):448-54. PubMed ID: 18344895 [Abstract] [Full Text] [Related]
11. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J. Cancer Epidemiol Biomarkers Prev; 2008 Sep 01; 17(9):2498-504. PubMed ID: 18768521 [Abstract] [Full Text] [Related]
12. Correlation of Helicobacter pylori and gastric carcinoma. Khanna AK, Seth P, Nath G, Dixit VK, Kumar M. J Postgrad Med; 2002 Sep 01; 48(1):27-8. PubMed ID: 12082323 [Abstract] [Full Text] [Related]
13. Clinical significance of IgG antibody titer against Helicobacter pylori. Tatemichi M, Sasazuki S, Inoue M, Tsugane S, JPHC Study Group. Helicobacter; 2009 Jun 01; 14(3):231-6. PubMed ID: 19702853 [Abstract] [Full Text] [Related]
14. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ. Anticancer Res; 1995 Jun 01; 15(2):603-6. PubMed ID: 7763044 [Abstract] [Full Text] [Related]
16. Helicobacter pylori-seronegative gastric carcinoma: a subset of gastric carcinoma with distinct clinicopathologic features. Wu MS, Hung HW, Wang JT, Tseng CC, Shun CT, Wang HP, Lee WJ, Lin JT. Hepatogastroenterology; 1998 Jul 01; 45(24):2432-6. PubMed ID: 9951939 [Abstract] [Full Text] [Related]
17. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer. Atalay C, Atalay G, Altinok M. Neoplasma; 2003 Jul 01; 50(3):185-90. PubMed ID: 12937851 [Abstract] [Full Text] [Related]
18. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Chomvarin C, Ottiwet O, Hahnvajanawong C, Intapan PM, Wongwajana S. Int J Infect Dis; 2009 Sep 01; 13(5):647-54. PubMed ID: 19233700 [Abstract] [Full Text] [Related]
20. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. Cao Q, Ran ZH, Xiao SD. J Dig Dis; 2007 Feb 01; 8(1):15-22. PubMed ID: 17261130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]